secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001171843-25-008045
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose reschedules special meeting for Hanmi acquisition pending SEC clearance
------------------------------------------------------------------------------

- Special meeting moved from Jan 16, 2026 to later date in January 2026.
- Rescheduling due to awaiting final SEC clearance of proxy statement.
- Unanimous board recommendation to vote for the continuance and arrangement.
- Record date remains Dec 12, 2025; no changes to matters to be voted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184325008045/0001171843-25-008045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184325008045/f8k_121925.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-008045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer